title: Highlights from the American Heart Association annual scientific sessions 2001: November 11 to 14, 2001.
authors.affiliation: Duke Clinical Research Institute, Durham, NC 27715, USA.
authors.forename: David E
authors.initials: DE
authors.lastname: Kandzari
authors.forename: Joseph
authors.initials: J
authors.lastname: Kay
authors.forename: J Conor
authors.initials: JC
authors.lastname: O'Shea
authors.forename: Benjamin H
authors.initials: BH
authors.lastname: Trichon
authors.forename: Mark
authors.initials: M
authors.lastname: Donahue
authors.forename: Lawrence
authors.initials: L
authors.lastname: Liao
authors.forename: Sunil V
authors.initials: SV
authors.lastname: Rao
mesh_terms: D000572:American Heart Association; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002340:Carotid Artery Diseases / Q000628:therapy*; D003327:Coronary Disease / Q000188:drug therapy / Q000517:prevention & control*; D023903:Coronary Restenosis; D016503:Drug Delivery Systems; D006801:Humans; D017239:Paclitaxel / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors; D016032:Randomized Controlled Trials as Topic; D015607:Stents; D062367:ortho-Aminobenzoates / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D062367:ortho-Aminobenzoates; C012293:tranilast; D017239:Paclitaxel